AMPK Promotes Xenophagy through Priming of Autophagic Kinases upon Detection of Bacterial Outer Membrane Vesicles
2019 · Cell Reports · 60 citations
https://doi.org/10.1016/j.celrep.2019.01.062
N
Nicholas D. LeBlond
Duke University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
531
Citations
10
h-index
10
i10-index
Nicholas D. LeBlond is an academic researcher from Duke University. The author has contributed to research in topics: Metabolism, Diabetes, and Cancer & Adipokines, Inflammation, and Metabolic Diseases & Peroxisome Proliferator-Activated Receptors. The author has an h-index of 10, co-authored 21 publications.
Papers by this author
worksThe apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation
2017 · Journal of Lipid Research · 39 citations
https://doi.org/10.1194/jlr.m077313
Myeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice
2020 · Journal of Lipid Research · 13 citations
https://doi.org/10.1194/jlr.ra120001040
AMPK-mediated regulation of endogenous cholesterol synthesis does not affect atherosclerosis in a murine Pcsk9-AAV model
2024 · Atherosclerosis · 6 citations
https://doi.org/10.1016/j.atherosclerosis.2024.117608
Why are treatment effects so small in musculoskeletal interventions? Part I: methodological and measurement considerations
2026 · Journal of Manual & Manipulative Therapy · 0 citations
https://doi.org/10.1080/10669817.2026.2621130
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat